Effects of health advocacy, counseling, and activation among older coronary heart disease (CHD) patients

Aging Clinical and Experimental Research

Volumn 17, Issue 6, 2005, Pages 472-478

  Salminen, Marika ^a,b   Isoaho, Raimo ^a,b,c   Vahlberg, Tero ^a   Ojanlatva, Ansa ^a   Irjala, Kerttu ^d,e   Kivelä, Sirkka Liisa ^a,d,f  

^a UNIVERSITY OF TURKU   (Finland)

^b Härkätie Health Center   (Finland)

^c Pori Health Center   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e Mehilainen Oy   (Finland)

^f SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

Health behavior; Late life CHD; Older persons; Secondary prevention

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; TRIACYLGLYCEROL; HYPOCHOLESTEROLEMIC AGENT;

AGED; AGING; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; EXERCISE; FEMALE; HEALTH CARE; HEALTH PROGRAM; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CORONARY ARTERY DISEASE; GERIATRIC ASSESSMENT; HEALTH BEHAVIOR; HEALTH CARE QUALITY; HYPERLIPIDEMIA; LONGITUDINAL STUDY; LOW FAT DIET; ORGANIZATION AND MANAGEMENT; PATIENT ADVOCACY; SMOKING; STATISTICS;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; BLOOD PRESSURE; CHOLESTEROL; CORONARY DISEASE; COUNSELING; DIET, FAT-RESTRICTED; EXERCISE; FEMALE; GERIATRIC ASSESSMENT; HEALTH BEHAVIOR; HUMANS; HYPERLIPIDEMIAS; LONGITUDINAL STUDIES; MALE; PATIENT ADVOCACY; PROGRAM EVALUATION; SMOKING;

EID: 33744967793     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03327414     Document Type: Article

References (15)

1. Carlsson R. Serum cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention programme. Scand Cardiovasc J 1998; 50 (Suppl): 1-20.
2. Strandberg T, Pitkälä K, Berglind S, et al. Possibilities of multifactorial cardiovascular disease prevention in patients aged 75 and older: a randomized controlled trial. Drugs and Evidence Based Medicine in the Elderly (DEBATE) Study. Eur Heart J 2003; 24: 1216-22.
3. Murchie P, Campbell NC, Ritchie LD, et al. Secondary prevention clinics for coronary heart disease: four year follow up of a randomized controlled trial in primary care. BMJ 2003; 326: 84-9.
4. Menard J, Colombet I, Chatelier, et al. Cardiovascular management of the elderly. Eur Heart J 2000; 2 (D Suppl): D11-2.
5. Connell CM. Older adults in health education research: some recommendations. Health Education Research 1999; 14: 427-31.
6. Strandberg T, Pitkälä K, Berglind S, et al. Multifactorial cardiovascular disease prevention in patients aged 75 years and older: A randomized controlled trial. Drugs and Evidence Based Medicine in the Elderly (DEBATE) Study. Am Heart J 2001; 142: 945-51.
7. Isoaho R, Puolijoki H, Huhti E, et al. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med 1994; 88: 571-80.
8. Löppönen M, Räihä I, Isoaho R, et al. Diagnosing cognitive impairment and dementia in primary health care - a more active approach is needed. Age Ageing 2003; 32: 606-12.
9. Friedewald WT, Levy R, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
10. Aronow WS, Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug. Am J Cardiol 2002; 89: 67-9.
11. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 563 high-risk individuals: a randomized placebo-controlled trial. Lancet 2003; 360: 7-22.
12. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002; 360: 1623-30.
13. Rossouw JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med 1990; 323: 1112-9.
14. Kohl HW 3rd. Physical activity and cardiovascular disease: evidence for a dose response. Med Sci Sports Exerc 2001; 33 (Suppl): 472-83.
15. Nissinen A, Kivelä S-L, Tuomilehto J, et al. Health behaviour of an elderly population in eastern Finland in 1982. Z Gerontol 1987; 20: 129-35.